The Florida Factor: Disparities Research in the Face of Anti-DEI Laws
As hundreds of cancer researchers and patient advocates traveled to Florida for the 16th AACR Conference on the Science...
As hundreds of cancer researchers and patient advocates traveled to Florida for the 16th AACR Conference on the Science...
They say age is just a number, but when it comes to cancer, getting older substantially increases your risk....
For the past several decades, researchers have been harnessing the power of the immune system to fight cancer. They...
Ancient Greek physician Hippocrates considered the human body to be a system composed of four balanced fluids, or “humours.”...
On Nov. 16, 2015, the AACR hosted several dozen patient advocates and executives from leading pharmaceutical companies, as well...
Many things come to mind at the mention of New Orleans—jazz, Cajun food, po’ boys, and French-inspired houses with...
Much of the excitement revolving around cancer immunotherapy is focused on checkpoint inhibitors – drugs that “release the brakes”...
This year has been a momentous year in healthcare, and, as some news outlets like Boston’s WBUR radio are...
Receiving a cancer diagnosis often means navigating numbers, such as estimates of the chance of recurrence. But cancer patients...
The U.S. Centers for Disease Control and Prevention (CDC) estimate that 80 to 90 percent of deaths from lung...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved a new molecularly targeted therapeutic called neratinib (Nerlynx)...
Improved patient outcomes come from new treatments. New treatments stem from successful clinical trials. Clinical trials build on discoveries...
This week, the U.S. Food and Drug Administration (FDA) added two new treatments to the armamentarium for hematologic oncologists...
A major objective of former Vice President Joe Biden’s National Cancer Moonshot Initiative is breaking down silos and sharing...
Over the course of the two-day AACR Virtual Annual Meeting I, more than 61,000 people from 140 countries around the...
In the final days of 2019, the U.S. Food and Drug Administration (FDA) expanded the use of a previously...
Finding a way to therapeutically target the so-called “undruggable” cancer proteins has long been a holy grail of researchers...
A look at the 10 most-read posts of the year on Cancer Research Catalyst illustrates the steady pace of...
The past month has seen the U.S. Food and Drug Administration (FDA) expand the use of four anticancer therapeutics,...
While Cancer Research Catalyst covers the spectrum of cancer research news, we weren’t surprised to discover that the hottest...
Screening for lung cancer using low-dose computed tomography (CT) was introduced in the United States in 2013. Recent data...
Each year in the United States, about 14,480 women are diagnosed with cervical cancer, and about 4,290 women die of...
In the beginning of his cancer journey, Edward Cutler felt unlucky. In 2012, he saw an ad suggesting that...
February is National Cancer Prevention Month. We recently had the opportunity to speak with American Association for Cancer Research...
Former Philadelphia Mayor Michael Nutter received a humanitarian award for his work as a prostate cancer advocate and dedication...
Two studies presented at the AACR Annual Meeting 2017 showed that tumors that have mutations in the proteins isocitrate...
The women bustle around a warm, colorful kitchen, making tamales for an upcoming family party. A woman in her...
An individual with hypertension visits their primary care physician and learns that two new medications for their condition have...
The FDA has approved expanding the use of the molecularly targeted therapeutic ibrutinib (Imbruvica) to include the treatment of...
With the late-breaking and clinical trial-placeholder abstract deadlines a week away, we thought it was a good time to...